Company profile
MyCardium AI
Precision Cardiac Diagnostics AI
- Industry
- Software Development
- Employees
- 47
- Headquarters
- Liverpool, Merseyside
- Founded
- 2022
- LinkedIn followers
- 2,875
- Office locations
- 1
MyCardium AI company summary
MyCardium AI is a company in the Software Development industry, headquartered in Liverpool, Merseyside, founded in 2022. On LinkedIn the company has around 47 employees and 2,875 followers. Its listed specialties include Artificial Intelligence, Clinical Trials, Software Development, Cardiac Magnetic Resonance Images, Echocardiograms.
What technology does MyCardium AI use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About MyCardium AI
We are MyCardium AI, transforming cardiac care through advanced artificial intelligence for imaging and diagnostics. MyCardium AI uses deep learning trained on thousands of expert-labelled heart scans to automatically analyse images, while keeping doctors in control of the final decisions. Founded in 2022 as a spin-out from University College London (UCL) by world-leading cardiologists and imaging researchers Professor James Moon, Professor Mark Westwood, and Professor Charlotte Manisty, we bring research-grade AI into real clinical practice to help diagnose heart disease earlier, faster, and more reliably. Our human-in-the-loop AI technology enables faster, more precise, and consistent image interpretation, reducing stress and freeing up time for clinicians so they can focus on patient care. Our products, 1CMR Pro (FDA 510(k) cleared, CE Class IIb) and EchoConfidence, combine pattern recognition beyond human vision with human oversight, suggesting measurements and outlines that clinicians review and validate. We also provide Core Lab services for multi-center clinical trials and research, accelerating and standardising imaging endpoints, critical for drug development and cardiac research. Headquartered in Liverpool, UK, our technology is used internationally across hospitals, research programmes, and clinical trials. ISO 13485 certification and regulatory approvals ensure safety, reliability, and trust. Our mission is to empower clinicians with intelligent tools that improve patient care, reduce workload, automating the routine, empowering the expert and advance the global understanding of heart disease, transforming cardiac diagnostics worldwide.
Specialties
Where is MyCardium AI located?
MyCardium AI lists 1 location.
Compare companies similar to MyCardium AI
More companies in Software Development.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
MyCardium AI mycardium.com | Software Development | 47 | 2022 | Liverpool, Merseyside |
 Vagas.com vagas.com.br | Software Development | 3,304 | 1999 | São Paulo, SP |
 Salesforce Work.com salesforce.com | Software Development | 87,907 | - | San Francisco, California |
 Microsoft github.com | Software Development | 6,587 | 2008 | San Francisco, CA |
 SAP Concur sap.com | Software Development | 147,691 | 1972 | Walldorf, BW |
 Upwork upwork.com | Software Development | 176,790 | 2015 | San Francisco, California, US |
 TechCrunch techcrunch.com | Software Development | 582 | - | San Francisco, California |
 Zoho zoho.com | Software Development | 30,854 | - | Chennai, Tamil Nadu |
 Canva canva.com | Software Development | 17,794 | 2012 | Surry Hills, New South Wales, AU |
 Atlassian atlassian.com | Software Development | 21,061 | 2002 | Sydney, NSW, AU |
 Shopee shopee.com | Software Development | 76,519 | - | Singapore, Singapore, SG |
Frequently asked questions about MyCardium AI
What does MyCardium AI do?
We are MyCardium AI, transforming cardiac care through advanced artificial intelligence for imaging and diagnostics. MyCardium AI uses deep learning trained on thousands of expert-labelled heart scans to automatically analyse images, while keeping doctors in control of the final decisions. Founded in 2022 as a spin-out from University College London (UCL) by world-leading cardiologists and imaging researchers Professor James Moon, Professor Mark Westwood, and Professor Charlotte Manisty, we bring research-grade AI into real clinical practice to help diagnose heart disease earlier, faster, and more reliably. Our human-in-the-loop AI technology enables faster, more precise, and consistent image interpretation, reducing stress and freeing up time for clinicians so they can focus on patient care. Our products, 1CMR Pro (FDA 510(k) cleared, CE Class IIb) and EchoConfidence, combine pattern recognition beyond human vision with human oversight, suggesting measurements and outlines that clinicians review and validate. We also provide Core Lab services for multi-center clinical trials and research, accelerating and standardising imaging endpoints, critical for drug development and cardiac research. Headquartered in Liverpool, UK, our technology is used internationally across hospitals, research programmes, and clinical trials. ISO 13485 certification and regulatory approvals ensure safety, reliability, and trust. Our mission is to empower clinicians with intelligent tools that improve patient care, reduce workload, automating the routine, empowering the expert and advance the global understanding of heart disease, transforming cardiac diagnostics worldwide.
How many employees does MyCardium AI have?
MyCardium AI has around 47 employees on LinkedIn.
Where is MyCardium AI headquartered?
MyCardium AI is headquartered in Liverpool, Merseyside.
When was MyCardium AI founded?
MyCardium AI was founded in 2022.
Build a lead list from companies like MyCardium AI
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.